ICU vs TCMD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

ICU

31.7
AI Score
VS
TCMD Wins

TCMD

46.3
AI Score

Investment Advisor Scores

ICU

32score
Recommendation
SELL

TCMD

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ICU TCMD Winner
Revenue 1.11M 160.97M TCMD
Net Income -7.25M 6.02M TCMD
Gross Margin 91.0% 76.4% ICU
Net Margin -653.2% 3.7% TCMD
Operating Income -7.39M 5.29M TCMD
ROE -168.8% 2.7% TCMD
ROA -83.8% 2.2% TCMD
Total Assets 8.65M 279.67M TCMD
Cash 6.96M 69.85M TCMD
Current Ratio 1.89 4.12 TCMD

Relative Price Performance (Last 90 Days)

ICU 1M: +62.8% · 3M: -1.5% TCMD 1M: -1.4% · 3M: -30.7%

Current Technical Phase

ICU

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 77

RSI (14): 77.5 · Price: $4.69

TCMD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.5%), weak momentum, RSI 41

RSI (14): 41.2 · Price: $22.10

Fundamentals Snapshot

Metric ICU TCMD
Market Cap — —
Forward P/E -2.0 15.2
Trailing P/E — 20.9
Revenue (TTM) — —
Revenue Growth 0.8% 0.1%
Gross Margin 0.9% 0.8%
Operating Margin -6.2% 0.1%
EPS -1.89 1.04
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, TCMD is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.